General Information
Revision date
2018-03-12
Product name
EnduraFlex CU524WC, VE524WCNTG; Plioweld LS585. Products Include TB/TG Versions Where Applicable
1.2.1 Relevant identified uses
Chlorobutyl Rubber Lining. For Professional Use Only
Icons in SDS
Company Information
company name
Blair Rubber Company
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317, H361
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
H361
Suspected of damaging fertility or the unborn child
Section 2
Classification (GHS-US)
Skin Sens. 1 H317 Repr. 2 H361
Hazard statements
see section 16 : H317 - May cause an allergic skin reaction. H361 - Suspected of damaging fertility or the unborn child.
2.2 Label elements
GHS-US Labeling
Hazard pictograms
GHS07 GHS08
Signal word
Warning
Precautionary statements
P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P261 - Avoid breathing dust, fumes from decomposition, vapors from decomposition. P272 - Contaminated work clothing must not be allowed out of the workplace. P280 - Wear protective gloves, protective clothing, and eye protection. P302+P352 - If on skin: Wash with plenty of water. P308+P313 - If exposed or concerned: Get medical advice/attention. P321 - Specific treatment (see section 4 on this SDS). P333+P313 - If skin irritation or rash occurs: Get medical advice/attention. P363 - Wash contaminated clothing before reuse. P405 - Store locked up. P501 - Dispose of contents/container in accordance with local, regional, national, and international regulations.
2.3 Other hazards
Exposure may aggravate those with pre-existing eye, skin, or respiratory conditions. When heated to decomposition, emits toxic fumes. Contains chemicals with hazards that are associated with their dust and usual forms. The hazards associated with these chemicals are not bioavailable under normal conditions of use due to the compounds being polymer bound. 2.4.
Ingredient(s) with unknown acute toxicity
0.54% of the mixture consists of ingredient(s) of unknown acute toxicity (Oral) 0.54% of the mixture consists of ingredient(s) of unknown acute toxicity (Dermal) 0.54% of the mixture consists of ingredient(s) of unknown acute toxicity (Inhalation (Dust/Mist))